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Abstract: Importance: Cerebral palsy describes the most common physical disability in childhood and
occurs in 1 in 500 live births. Historically, the diagnosis has been made between age 12 and 24 months
but now can be made before 6 months’ corrected age. Objectives: To systematically review best available
evidence for early, accurate diagnosis of cerebral palsy and to summarize best available evidence about
cerebral palsy-specific early intervention that should follow early diagnosis to optimize neuroplasticity
and function. Evidence Review: This study systematically searched the literature about early diagnosis of
cerebral palsy in MEDLINE (1956-2016), EMBASE (1980-2016), CINAHL (1983-2016), and the Cochrane
Library (1988-2016) and by hand searching. Search terms included cerebral palsy, diagnosis, detection,
prediction, identification, predictive validity, accuracy, sensitivity, and specificity. The study included
systematic reviews with or without meta-analyses, criteria of diagnostic accuracy, and evidence-based
clinical guidelines. Findings are reported according to the PRISMA statement, and recommendations
are reported according to the Appraisal of Guidelines, Research and Evaluation (AGREE) II instrument.
Findings: Six systematic reviews and 2 evidence-based clinical guidelines met inclusion criteria. All
included articles had high methodological Quality Assessment of Diagnostic Accuracy Studies (QUADAS)
ratings. In infants, clinical signs and symptoms of cerebral palsy emerge and evolve before age 2 years;
therefore, a combination of standardized tools should be used to predict risk in conjunction with clinical
history. Before 5 months’ corrected age, the most predictive tools for detecting risk are term-age magnetic
resonance imaging (86%-89% sensitivity), the Prechtl Qualitative Assessment of General Movements
(98% sensitivity), and the Hammersmith Infant Neurological Examination (90% sensitivity). After 5
months’ corrected age, the most predictive tools for detecting risk are magnetic resonance imaging (86%-
89% sensitivity) (where safe and feasible), the Hammersmith Infant Neurological Examination (90%
sensitivity), and the Developmental Assessment of Young Children (83% C index). Topography and
severity of cerebral palsy are more difficult to ascertain in infancy, and magnetic resonance imaging and
the Hammersmith Infant Neurological Examination may be helpful in assisting clinical decisions. In
high-income countries, 2 in 3 individuals with cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will
have normal intelligence. Conclusions and Relevance: Early diagnosis begins with a medical history and
involves using neuroimaging, standardized neurological, and standardized motor assessments that indicate
congruent abnormal findings indicative of cerebral palsy. Clinicians should understand the importance of
prompt referral to diagnostic-specific early intervention to optimize infant motor and cognitive plasticity,
prevent secondary complications, and enhance caregiver well-being.
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IMPORTANCE Cerebral palsy describes themost common physical disability in childhood and
occurs in 1 in 500 live births. Historically, the diagnosis has beenmade between age 12 and 24
months but now can bemade before 6months’ corrected age.
OBJECTIVES To systematically review best available evidence for early, accurate diagnosis of
cerebral palsy and to summarize best available evidence about cerebral palsy–specific early
intervention that should follow early diagnosis to optimize neuroplasticity and function.
EVIDENCE REVIEW This study systematically searched the literature about early diagnosis of
cerebral palsy in MEDLINE (1956-2016), EMBASE (1980-2016), CINAHL (1983-2016), and the
Cochrane Library (1988-2016) and by hand searching. Search terms included cerebral palsy,
diagnosis, detection, prediction, identification, predictive validity, accuracy, sensitivity, and
specificity. The study included systematic reviews with or without meta-analyses, criteria of
diagnostic accuracy, and evidence-based clinical guidelines. Findings are reported according
to the PRISMA statement, and recommendations are reported according to the Appraisal of
Guidelines, Research and Evaluation (AGREE) II instrument.
FINDINGS Six systematic reviews and 2 evidence-based clinical guidelines met inclusion
criteria. All included articles had highmethodological Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) ratings. In infants, clinical signs and symptoms of cerebral palsy
emerge and evolve before age 2 years; therefore, a combination of standardized tools should
be used to predict risk in conjunction with clinical history. Before 5months’ corrected age, the
most predictive tools for detecting risk are term-agemagnetic resonance imaging (86%-89%
sensitivity), the Prechtl Qualitative Assessment of General Movements (98% sensitivity), and
the Hammersmith Infant Neurological Examination (90% sensitivity). After 5 months’
corrected age, themost predictive tools for detecting risk are magnetic resonance imaging
(86%-89% sensitivity) (where safe and feasible), the Hammersmith Infant Neurological
Examination (90% sensitivity), and the Developmental Assessment of Young Children (83%
C index). Topography and severity of cerebral palsy are more difficult to ascertain in infancy,
andmagnetic resonance imaging and the Hammersmith Infant Neurological Examinationmay
be helpful in assisting clinical decisions. In high-income countries, 2 in 3 individuals with
cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will have normal intelligence.
CONCLUSIONS AND RELEVANCE Early diagnosis begins with amedical history and involves
using neuroimaging, standardized neurological, and standardizedmotor assessments that
indicate congruent abnormal findings indicative of cerebral palsy. Clinicians should
understand the importance of prompt referral to diagnostic-specific early intervention to
optimize infant motor and cognitive plasticity, prevent secondary complications, and enhance
caregiver well-being.
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A ccording toa2007report, “Cerebralpalsy is agroupofper-manent disorders of the development of movement andposture, causing activity limitation, that are attributed to
non-progressive disturbances that occurred in the developing fe-
tal or infantbrain.”1(p9) Cerebral palsy is a clinical diagnosis basedon
a combination of clinical and neurological signs. Diagnosis typically
occurs between age 12 and 24 months.2-4 The following 4 motor
types exist but may emerge and change during the first 2 years of
life: (1) spasticity (85%-91%); (2)dyskinesia (4%-7%), includingdys-
tonia and athetosis; (3) ataxia (4%-6%); and (4) hypotonia (2%),
which is not classified in all countries.2 Dyskinesia, ataxia, and hy-
potonia usually affect all 4 limbs, whereas spasticity is categorized
topographically as (1) unilateral (hemiplegia) (38%) and (2) bilat-
eral, includingdiplegia (lower limbsaffectedmore thanupper limbs)
(37%) andquadriplegia (all 4 limbs and trunk affected) (24%).2 Co-
morbiditiesand functional limitationsarecommonanddisabling, in-
cluding chronic pain (75%), epilepsy (35%), intellectual disability
(49%),musculoskeletalproblems (eg,hipdisplacement) (28%),be-
havioral disorders (26%), sleep disorders (23%), functional blind-
ness (11%), and hearing impairment (4%).5
Cerebral palsy is the most common physical disability in child-
hood, with a prevalence of 2.1 cases per 1000 in high-income
countries.6 The prevalence is declining in Australia and Europe.7,8
Exact rates in countriesof lowtomiddle incomeare less certain9but
appear tobehigher,withworsephysicaldisability,becauseofgreater
infectious disease burden and prenatal and perinatal care
differences.10 The complete causal path to cerebral palsy is unclear
in approximately 80% of cases, but risk factors are often identifi-
able fromhistory takingaboutconception,pregnancy,birth, and the
postneonatal period.11 The full causal path is a complex interplaybe-
tween several risk factors across multiple epochs,11 including new
evidence suggesting that 14% of cases have a genetic
component.12-14 Early diagnosis does not preclude further specific
etiological investigation, and identifyinga specific etiologydoesnot
then preclude individuals from also having cerebral palsy. Genetic
advances are likely to soon amend the diagnostic process.
Our primary objective was to systematically review best avail-
ableevidence forearly, accuratediagnosisof cerebral palsy.Our sec-
ondary objective was to summarize best available evidence about
cerebral palsy–specific early intervention that should followearlydi-
agnosis to optimize neuroplasticity and function.
Methods
Weconducteda systematic reviewtodevelopan international clini-
cal practice guideline in accord with the World Health Organiza-
tion’s Handbook for Guideline Development15 and the Institute of
Medicine’s standards.16 We followed the Equator Network report-
ing recommendations outlined in the Appraisal of Guidelines, Re-
searchandEvaluation (AGREE) II instrument17 and thePreferredRe-
porting Items for Systematic Reviews andMeta-analyses (PRISMA)
statement.18 We systematically searched MEDLINE (1956-2016),
EMBASE (1980-2016), CINAHL (1983-2016), and the Cochrane Li-
brary (1988-2016)andhandsearchedusing the following terms: ce-
rebral palsy, diagnosis, detection, prediction, identification, predic-
tive validity, accuracy, sensitivity, and specificity. We included
systematic reviewswith or withoutmeta-analyses, criteria of diag-
nostic accuracy, andevidence-basedclinical guidelines.Qualitywas
appraisedusingtheQualityAssessmentofDiagnosticAccuracyStud-
ies (QUADAS) methodological rating checklist for systematic re-
views of diagnostic accuracy.19
The Grading of Recommendations Assessment, Develop-
ment, andEvaluation (GRADE) frameworkwasused to assessqual-
ity and formulate recommendations along a 4-part continuum, in-
cluding strong for, conditional for, conditional against, and strong
against.20 As per the GRADE method, we weighed (1) the balance
betweendesirable andundesirable consequencesofdifferentman-
agement strategies or not acting; (2) family preferences, including
benefits vs risks and inconvenience; and (3) cost. Recommenda-
tionswerediscussed face-to-faceamongall authors, and themanu-
script was reviewed, edited, and agreed on by all coauthors. Au-
thors were clinicians involved in the diagnosis of cerebral palsy,
including neurologists, pediatricians, neonatologists, rehabilita-
tion specialists, general practitioners, neuroradiologists, psychia-
trists, physical therapists, psychologists, occupational therapists,
speech pathologists, nurses, and early educators. Individuals with
cerebral palsy and parents also contributed as equal authors, en-
suring that recommendations addressed their views and prefer-
ences.
Results
Six systematic reviews21-26 and 2 evidence-based clinical
guidelines27,28met inclusion criteria. Themethodological quality of
the evidence was very high (eTable in the Supplement), enabling
strongGRADE recommendations.20Many standardized tools exist
that predict risk of cerebral palsy early. Best available evidencewas
summarized(eTable intheSupplement),andaPRISMAdiagramsum-
marized study flow (eFigure in the Supplement).
Advances in Diagnosis: Early Clinical Diagnosis
Is Now Possible
Before age 12 to 24 months was historically regarded as the latent
or silent period where cerebral palsy could not be identified accu-
rately. Experts now consider the silent period as outdated because
Key Points
Question What are themost accurate evaluations for diagnosing
cerebral palsy early?
Findings In this systematic review of the literature, we found
diagnosis can be accurately made before 6months’ corrected age.
Before 5months’ corrected age, magnetic resonance imaging plus
the General Movements Assessment or the Hammersmith Infant
Neurological Examination are recommended; after 5 months’
corrected age, magnetic resonance imaging (where safe and
feasible), the Hammersmith Infant Neurological Examination, and
the Developmental Assessment of Young Children are
recommended.
Meaning Early diagnosis should be the standard of care because
contemporary early interventions optimize neuroplasticity and
functional outcomes.
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cerebral palsy or “high risk of cerebral palsy” can be accurately pre-
dicted before age 6months’ corrected age.
The 3 tools with best predictive validity for detecting cerebral
palsybefore5months’ correctedageare (1)neonatalmagnetic reso-
nance imaging (MRI) (86%-89% sensitivity),21,27 (2) the Prechtl
Qualitative Assessment of General Movements (GMs) (98%
sensitivity),21 and (3) theHammersmith InfantNeurological Exami-
nation (HINE) (90% sensitivity)25 (eTable in the Supplement). Af-
ter 5 months’ corrected age, the most predictive tools for detect-
ing risk are MRI (86%-89% sensitivity) (where safe and feasible),
theHINE (90%sensitivity), and theDevelopmental Assessment of
Young Children (83% C index). High-quality evidence also indi-
cates that a trajectory of abnormal GMs or HINE scores, in combi-
nation with abnormal MRI, producing congruent findings, is even
more accurate than individual clinical assessments in isolation.21,25
Tomake an early clinical diagnosis before 6months’ corrected
age, a combination of assessments with strong predictive validity
coupledwith clinical reasoning is recommended.We havemade 12
recommendations from best available evidence (Table 1). A highly
experienced clinical team should ideally conduct and interpret the
standardized assessments and then communicate the news com-
passionately.
InterimHigh Risk of Cerebral Palsy Clinical Diagnosis
When the clinical diagnosis is suspected but cannot be made with
certainty, we recommend using the interim clinical diagnosis of
high risk of cerebral palsy until a diagnosis is confirmed. We rec-
ommend specifying cerebral palsy because infants with cerebral
palsy require and benefit from different early interventions than
infants “at risk of developmental delay,” “at risk of autism,” “at risk
of harm,” or with “social risk.” When the infant is perceived to be at
risk of cerebral palsy, he or she should be referred for cerebral
palsy–specific early intervention (see the Advances in Treatment
section), with regular medical, neurological, and developmental
monitoring from the infant’s pediatrician or neurologist to assist
with forming a diagnostic picture. To assign the interim clinical
diagnosis of high risk of cerebral palsy, the infant must have motor
dysfunction (essential criterion) and at least one of the other 2
additional criteria.
Essential Criterion (Required)
Motor Dysfunction
In motor dysfunction, the infant’s quality of movement is reduced
(eg, absent fidgetyGMs)29orneurologically abnormal (eg, earlyob-
servable hand asymmetry or suboptimal HINE scores).30 In addi-
tion, the infant’smotor activitiesmay be substantially below those
expected for chronological age (eg, abnormal score on a standard-
izedmotor assessment or parent and caregiver or clinical observa-
tions of head lag, not sitting, inability to grasp, or not reaching for a
toy when appropriate).
As a caveat, in milder presentations, especially unilateral cere-
bral palsy, it is possible for an infant to scorewithin thenormal range
on a standardized motor assessment, while still displaying abnor-
mal movements. For example, an infant with hemiplegia might ob-
tain a normal fine-motor score but complete the assessment one-
handed. Similarly, an infantwith diplegiamay achievenormal upper
limb scores and abnormal lower limb scores, producing a combined
total motor score within the normal range. Therefore, it is essential
that assessments be carried out by a professional skilled at deter-
mining atypical movement from variation in typical movement.
Additional Criteria (at Least One Required)
Abnormal Neuroimaging
Abnormal MRI21,27 with or without serial cranial ultrasound in pre-
term infants21,28 may identify neuroanatomical abnormalities pre-
dictive of cerebral palsy. Themost predictive patterns are (1) white
matter injury (cystic periventricular leukomalacia or periventricu-
lar hemorrhagic infarctions) (56%), (2) cortical and deep graymat-
ter lesions (basalgangliaor thalamus lesions,watershed injury [para-
sagittal injury],multicystic encephalomalacia, or stroke) (18%), and
(3)brainmaldevelopments (lissencephaly, pachygyria, cortical dys-
plasia, polymicrogyria, or schizencephaly) (9%).
Clinical History Indicating Risk for Cerebral Palsy
Preconception risks include history of stillbirths, miscarriages, low
socioeconomic status, assisted reproduction, and abnormal ge-
netic copy number variations.
Pregnancyrisks includegenetics,birthdefects,multiples,males,
maternal thyroid disease or preeclampsia, infection, intrauterine
growth restriction, prematurity, and substance abuse.
Perinatal birth risks include acute intrapartum hypoxia-
ischemia, seizures, hypoglycemia, jaundice, and infection.
Postneonatal risks include stroke, infection, surgical complica-
tions, and accidental andnonaccidental brain injury31 occurringbe-
fore age 24 months, as per the Surveillance of Cerebral Palsy Eu-
rope and Australian Cerebral Palsy Register inclusion criteria.
Two Early Detection Pathways Based on Different Risks
Half of all infantswith cerebral palsy have high-risk indicators iden-
tifiable in the newborn period, enabling early screening31 (eg, pre-
maturity, atypical intrauterinegrowth, encephalopathy, genetic ab-
normalities, and seizures). We have described this population as
having “newborn-detectable risks for cerebral palsy,” and this path-
way occurs before 5months’ corrected age. For the other half of all
infants with cerebral palsy, the pregnancy and labor may have ap-
peared to be uneventful,31 and parents, caregivers, or community-
based professionals first notice delayedmotor milestones (eg, not
sitting at 9months or hand asymmetry). This findingmay be espe-
cially true for infants with unilateral cerebral palsy, who oftenmas-
ter early rudimentarymotor skills, such as smiling, swallowing, and
head control, and it is not until they attempt more complex motor
skills, suchasgrasp, that asymmetriesbecomeobservable.Wehave
described this population as having “infant detectable risks for ce-
rebral palsy,” and thispathwayoccurs after5months’ correctedage.
Wedevelopedaconceptual framework for earlydiagnosisbasedon
these2pathways toensure that themost sensitiveandspecific tools
areusedto reduce false-positiveandfalse-negative results.Theclini-
cal diagnostic pathway algorithm for these 2 groups varies because
the tools havedifferent psychometric properties dependingon the
infant’s age (Figure).
Determining Severity
Parents or caregivers will want to learn about the severity of their
infant’sphysicaldisability tounderstandhisorhercapabilities toplan
their future. In infants younger than 2 years, motor severity is diffi-
cult to accurately predict for the following reasons: (1) almost half
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Table 1. Early Detection and Diagnosis Recommendations FromBest Available Evidence
Recommendations Strength of Recommendations and Quality of Evidence
1.0 The clinical diagnosis of CP can and should be made as early as possible so that:
• The infant can receive diagnostic-specific early intervention and surveillance to optimize
neuroplasticity and prevent complications
• The parents can receive psychological and financial support (when available)
Strong recommendation based on moderate-quality
evidence for infant and parent outcomes
1.1 When the clinical diagnosis is suspected but cannot be made with certainty, the interim clinical
diagnosis of high risk of CP should be given so that:
• The infant can receive diagnostic-specific early intervention and surveillance to optimize
neuroplasticity and prevent complications
• The parents can receive psychological and financial support (when available)
• Ongoing diagnostic monitoring can be provided until a diagnosis is reached
Strong recommendation based on moderate-quality
evidence for infant and parent outcomes
2.0 Early standardized assessments and investigations for early detection of CP should always be
conducted in populations with newborn-detectable risks (ie, infants born preterm, infants with
neonatal encephalopathy, infants with birth defects, and infants admitted to the NICU)
Strong recommendation based on high-quality evidence
of test psychometrics
Early Detection of CP Before 5 mo CA
3.0 Option A: The most accurate method for early detection of CP in infants with newborn-detectable
risks and younger than 5 mo (CA) is to use a combination of a standardized motor assessment and
neuroimaging and history taking about risk factors
Strong recommendation based on high-quality evidence
of test psychometrics in newborn-detectable risk
populations
Standardized motor assessment
3.1 Test: GMs to identify motor dysfunction (95%-98% predictive of CP), combined with neuroimaging
Strong recommendation based on high-quality evidence
of test psychometrics in newborn-detectable risk
populations
Neuroimaging
3.2 Test: MRI (before sedation is required for neuroimaging) to detect abnormal neuroanatomy in
the motor areas of the brain (80%-90% predictive of CP). Note that normal neuroimaging does not
automatically preclude the diagnosis of risk of CP
Strong recommendation based on high-quality evidence
of test psychometrics in newborn-detectable risk
populations
4.0 Option B: In contexts where the GMs assessment is not available or MRI is not safe or affordable
(eg, in countries of low to middle income), early detection of CP in infants with newborn-detectable
risks and younger than 5 mo (CA) is still possible and should be carried out to enable access to early
intervention
Strong recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized neurological assessment
4.1 Test: HINE (scores <57 at 3 mo are 96% predictive of CP)
Strong recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized motor assessment
4.2 Test: TIMP
Conditional recommendation based on low-quality
evidence of test psychometrics in at-risk populations
Early Detection of CP After 5 mo CA
Accurate early detection of CP in those with infant-discernible risks and age 5-24 mo can and should still occur as soon as possible, but different diagnostic tools
are required
5.0 Any infant with:
(a) Inability to sit independently by age 9 mo, or
(b) Hand function asymmetry, or
(c) Inability to take weight through the plantar surface (heel and forefoot) of the feet should receive
standardized investigations for CP
Strong recommendation based on high-quality evidence
of motor norms
6.0 Option A: The most accurate method for early detection of CP in those with infant detectable
risks older than 5 mo (corrected for prematurity) but younger than 2 y is to use a combination of a
standardized neurological assessment, neuroimaging, and a standardized motor assessment with a
history taking about risk factors
Conditional recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized neurological assessment
6.1 Test: HINE (90% predictive of CP). Those with HINE scores <73 (at 6, 9, or 12 mo) should be
considered at high risk of CP. HINE scores <40 (at 6, 9, or 12 mo) almost always indicate CP,
combined with neuroimaging and standardized motor assessments
Conditional recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Neuroimaging
6.2 Test: MRI to detect abnormal neuroanatomy in the motor areas of the brain (sedation may be
required from >6 wk up to age 2 y). Well-defined lesions can be seen early, but subtle white matter
lesions may be difficult to detect owing to rapid growth, myelination, and activity-dependent
plasticity. Repeated MRI scans are recommended at age 2 y for infants with initially normal findings on
MRI (at 12-18 mo) but persistent motor or neurological abnormality, combined with standardized
motor assessments
Conditional recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized motor assessment
6.3 Test: DAYC for parents to self-report and quantify motor delay (89% predictive of CP)
Additional assessments can improve triangulation of findings
6.4 Tests: AIMS (86% predictive of an abnormal motor outcome) and NSMDA (82% predictive of an
abnormal motor outcome)
Conditional recommendation based on low- to
moderate-quality evidence of test psychometrics in
newborn-detectable risk populations
7.0 Option B: In contexts where MRI is not safe or affordable, early detection of CP is still possible in
those with infant detectable risks between 5 and 24 mo CA and should be carried out to enable
access to early intervention
Strong recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized neurological assessment
7.1 Test: HINE (90% predictive of CP at age 2-24 mo)
HINE scores at 6, 9, or 12 mo:
<73 Indicates high risk of CP
<40 Indicates abnormal outcome, usually CP
Strong recommendation based on moderate-quality
evidence of test psychometrics in newborn-detectable
risk populations
Standardized motor assessment
7.2 Test: DAYC to quantify motor delay (89% predictive of CP)
7.3 Test: MAI to quantify motor delay (73% predictive of CP)
Conditional recommendation based on low- to
moderate-quality evidence of test psychometrics in
newborn-detectable risk populations
(continued)
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of all infants younger than 2 years have their GrossMotor Function
Classification System (GMFCS) reclassified, (2) little natural history
data exist about infants with cerebral palsy (eg, the onset of spas-
ticity, dyskinesia, or contractures), (3) motor skills are developing,
(4) thepresenceorabsenceofhypertonia changesandevolves, and
(5) there is rapid brain growth and use-dependent reorganization
in response to caregiving and therapy. In children 2 years or older,
severity is reliably classified using the 5-level GMFCS Extended &
Revised.32 In infants younger than 2 years, prediction of motor se-
verity should be made cautiously using standardized tools, includ-
ing the cutoff scores on the HINE, combined with neuroimaging
data.25 Parents or caregiversmaymistakenly assume that the diag-
nosismeans their childwill need awheelchair and have an intellec-
tual disability. However, in high-income countries, population data
indicate that 2 in 3 individuals with cerebral palsy will walk, 3 in 4
will talk, and 1 in 2 will have normal intelligence.5
DeterminingMotor Type and Topography
Themotor types and topographyof cerebral palsymayemergeand
change during the first 2 years of life. Cerebral palsy can be difficult
to accurately classify early, but clinical signs exist33-37 (Table 2). For
example, the onset of spasticity may occur after age 1 year; there-
fore, the absence of early detectable spasticity does notmean that
the infant does not have spastic cerebral palsy. In addition, infants
mayhavemore thanonemotordisorderbecausespasticityanddys-
tonia often coexist. As the infant’s voluntary activity levels in-
crease, some symptoms may resolve (eg, nonuse of a limb), while
other symptoms may worsen (eg, increased involuntary dystonic
Table 1. Early Detection and Diagnosis Recommendations FromBest Available Evidence (continued)
Recommendations Strength of Recommendations and Quality of Evidence
Early Detection of Motor Severity of CP
Prognosis of long-term motor severity is most accurate in children older than 2 y using the GMFCS
8.0 In infants younger than 2 y, prognosis of motor severity predictions should be made cautiously
and always involve the use of standardized tools because incomplete development of voluntary motor
skills or abnormal tone might confound clinical observations. Motor severity of CP in those younger
than 2 y is most accurately predicted using the following:
Conditional recommendation based on low-quality
evidence
Standardized neurological assessment
8.1 Test: HINE. Cutoff scores predict the probable severity
HINE scores at 3, 6, 9, or 12 mo:
• 50-73 Indicates likely unilateral CP (ie, 95%-99% will walk)
• <50 Indicates likely bilateral CP
HINE scores at 3-6 mo:
• 40-60 Indicates likely GMFCS I-II
• <40 Indicates likely GMFCS III-V
Conditional recommendation based on moderate-quality
evidence in newborn-detectable risk populations
Neuroimaging
8.2 Test: MRI
Nonambulant CP is more likely after:
• Bilateral parenchymal hemorrhages (grade IV)
• Bilateral cystic periventricular leukomalacia (grade III)
• Brain maldevelopment
• Basal ganglia injury
Ambulant CP is more likely after:
• Unilateral lesions (grade IV hemorrhage or perinatal arterial ischemic stroke)
• Periventricular leukomalacia (noncystic)
• Moderate to severe white matter injury
Normal imaging does not preclude CP, and abnormal findings on MRI imaging does not automatically
precede CP
Conditional recommendation based on moderate-quality
evidence in newborn-detectable risk populations
Early Detection of Motor Subtype and Topography of CP
9.0 Early detection of motor subtype and topography can be difficult in those younger than 2 y,
but wherever possible it is important to identify unilateral vs bilateral CP early because the early
interventions (eg, constraint-induced movement therapy) and long-term musculoskeletal outcomes
and surveillance needs differ (eg, hip surveillance)
Conditional recommendation based on low- to
high-quality evidence
Early Intervention
10.0 The clinical diagnosis of CP or the interim diagnosis of high risk of CP should always be followed
by a referral to CP-specific early intervention (eg, constraint-induced movement therapy and hip
surveillance). Parent concern is a valid reason to trigger formal diagnostic investigations and referral
to early intervention
Strong recommendation based on low- to high-quality
evidence
Early Detection of Associated Impairments
11.0 The clinical diagnosis of CP or the interim diagnosis of high risk of CP should always include
standard medical investigations for associated impairments and functional limitations (eg, vision
impairment, hearing impairment, and epilepsy)
Strong recommendation based on high-quality
population register evidence of rates of associated
impairments
Communicating the Diagnosis Well to Parents
12.0 Parents experience grief and loss at the time of diagnosis or high-risk notification; therefore,
communication with a family should be a series of well-planned and compassionate conversations.
Communication should be face-to-face, with both parents or caregivers present (where appropriate),
private, honest, jargon free, and with empathic communication tailored to the family, followed by
written information, identification of strengths, invitation to ask questions, discussion of feelings,
recommendations to use parent-to-parent support, and arrangement of early intervention
Strong recommendation based on high-quality
qualitative parent interviews
Abbreviations: AIMS, Alberta Infant Motor Scale; CA, corrected age; CP, cerebral
palsy; DAYC, Developmental Assessment of Young Children; GMFCS, Gross
Motor Function Classification System; GMs, Prechtl Qualitative Assessment of
General Movements; HINE, Hammersmith Infant Neurological Examination;
MAI, Motor Assessment of Infants; MRI, magnetic resonance imaging;
NICU, neonatal intensive care unit; NSMDA, Neuro Sensory Motor Development
Assessment; TIMP, Test of Infant Motor Performance.
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posturing in response to voluntary movement). Wherever pos-
sible,differentiatebetweenunilateral vsbilateral cerebralpalsyearly
because treatments differ.5,38
False Positives and False Negatives
Withouta laboratorybiomarker, anearlydiagnosis isnotalwaysclini-
cally clear-cut because of the possibility of false positives and false
Figure. Algorithm for Early Diagnosis of Cerebral Palsy or High Risk of Cerebral Palsy
Conduct a medical history and clinical examination
with or without investigations for etiology and
differential diagnoses (as indicated)
Newborn detectable risks Infant detectable risks
Encephalopathy History or neurological risk
factors (eg, birth defect, IUGR)
Parent identified concern Unable to sit at 9 mo or hand
asymmetry
Preterm
Risks or concerns warrant an investigation for CP
Clinical neurological examination
Neurological imaging
Motor tests
Combined assessment data indicates
<5 mo CA
3.1 GMs 4.2 TIMP
4.1 HINE
+
+
3.2 MRI
>5 mo CA
A B A B
6.3 AIMS 6.3 NSM DA 7.2 DAYC 7.3 MAI
7.1 HINE
++
6.3 DAYC
6.1 HINE
+
6.2 MRI
8.0 Determine preliminary severity of CP
9.0 Determine preliminary topography
1.1 High risk of CP
11.0 Assess for associated impairments
1.1 Definitely CP
8.1 HINE ≥40
Likely ambulant
8.1 MRI WMI
Likely nonambulant
8.1 HINE <40 8.1 MRI GMI
12.0 Communicate findings to parents compassionately
10.0 Arrange early intervention and parent support Confirm diagnosis
1.1 Definitely NOT CP
As indicated, continue testing
for differential diagnoses and
relevant associated impairments
1.1 Unclear
Monitor
A indicates the best available evidence pathway. B indicates the next best
available evidence pathway when some pathway A tools are not available. The
numerals correspond to the numbering in Table 1. AIMS indicates Alberta Infant
Motor Scale; CA, corrected age; CP, cerebral palsy; DAYC, Developmental
Assessment of Young Children; GMs, Prechtl Qualitative Assessment of General
Movements; HINE, Hammersmith Infant Neurological Examination;
IUGR, interuterine growth restriction; MAI, Motor Assessment of Infants;
MRI, magnetic resonance imaging; NSMDA, Neuro Sensory Motor Development
Assessment; TIMP, Test of Infant Motor Performance; andWMI, white matter
injury.
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negatives.22 Experienced clinicians acknowledge that, because all
infants have an expanding and changing voluntary motor reper-
toire, determining whether their currentmotor dysfunction is per-
manent and causing long-term activity limitations, as per the inter-
national definition,1 is difficult. False negatives can occur for the
following reasons: (1) there is a latency between the initial brain le-
sion and the later onset of clinical neurological signs (eg, exagger-
ated spasticity or dystonia from voluntary movement25), (2) ap-
proximately 10% have normal neuroimaging,27 (3) half have a
seeminglyuneventful pregnancyandbirth,31 and (4)one-thirdhave
themildest form (GMFCS I)2,32 andmay initially achieve all of their
motormilestonesontime,offering false reassuranceabout theirmo-
tor development. False positives can also occur because prematu-
rity, stroke, and encephalopathy do not always result in long-term
motor disabilities.25,31 Australian cerebral palsy population register
data indicate that less than 5% of registrations are false-positive
diagnoses.2 In almost all of these instances, the infant was rediag-
nosedashaving another neurological disability (eg, intellectual dis-
ability or autism), not a normal developmental outcome.11
Eighty-six percent of parents of a childwith cerebral palsy sus-
pect it before the clinical diagnosis ismade.39 Population data indi-
cate that seeking to avoid false-positive results bydelayingdiagno-
sis is harmful to parent and caregiver well-being.39 Parents and
caregiversdissatisfiedwithaprolongeddiagnosticprocessaremore
likely to experience depression39 and lasting anger.40 Parents and
caregivers acknowledge that, while receiving the diagnosis is al-
ways difficult, they prefer to know earlier rather than later so that
theycanassist in their infant’sdevelopment.39Earlydetection is im-
portant for thewhole familyunitbecause ithelps fosteracceptance41
and leads to increased confidence in the infant’s medical team.39
Earlydetectionallows improvedaccess toearly interventionandef-
ficient use of resources.
Advances in Treatment: Cerebral Palsy–Specific
Early Intervention Improves Outcomes
Neuroscienceevidence indicates thatbraindevelopmentandrefine-
mentof themotor systemcontinuepostnatally,drivenbymotorcor-
texactivity.42,43Earlyactivemovementand interventionareessential
because infants who do not actively use their motor cortex risk los-
ing cortical connections and dedicated function.42,43 Furthermore,
there is increasing evidence that the infant’smotor behavior, via dis-
covery and interaction with the environment, controls and gener-
ates the growth anddevelopment ofmuscle, ligament, andbone, as
well asdrivingongoingdevelopmentof theneuromotorsystem.44-48
Table 2. Clinical Signs IndicatingMotor Type and Topography in Infants
Unilateral Spastic Hemiplegia Bilateral Spastic Diplegia Bilateral Spastic Quadriplegia Dyskinesia Ataxia
GMs34
• Poor repertoire or cramped
synchronized GMs, followed by
absent fidgety movements plus an
asymmetry in segmental
movements (eg, wrist or hand).
Note that some cases of hemiplegic
CP may be missed by GMs
• Cramped synchronized
GMs, followed by absent
fidgety movements
• Early onset and long duration
of cramped synchronized GMs,
followed by absent fidgety
movements
• Poor repertoire GMs,
followed by absent fidgety
movements with circular
arm movements and
finger spreading
• Unknown
MRI35,36
• Focal vascular insults (24%)
• Malformations (13%)
• Unilateral hemorrhage (grade IV)
with porencephaly
• Lesions in the parietal white
matter involving the trigone
• Middle cerebral artery stroke with
asymmetry of myelination of the
PLIC
• Bilateral white matter
injury (31%-60%)
• Cystic PVL (grade II-III)
with sparse or absent
myelination of the PLIC
• Moderate to severe white
matter injury (also known
as PVE)
• Gray matter injury (34%)
• Malformations (16%)
• Cystic PVL (grade III) with
absent myelination of the PLIC
• Severe white matter injury
with or without deep nuclear
gray matter
• Gray matter injury
(21%) with thalamic and
lentiform nuclear injury
• Malformations (18%)
• Normal imaging (24%-57%)
• Cerebellar injury
HINE Scores37
50-73 <50 <50
<40 GMFCS level IV-V
<50 Unknown
Motor Tests
• Asymmetrical hand preference
• Stuck in floor sitting (ie, unable to
transition out of sitting)
• Cruises or steps consistently in
one direction or with the same leg
always leading
• Reduced variation in motor
behavior
• Good hand function
compared with lower limb
function
• Dislike or avoidance of
floor sitting
• Weight bears on toes
• Reduced variation in
motor behavior
• Head lag
• Persistent rounded back in
supported sitting
• Bilateral fisted hands
• Slow to reach and grasp with
either hand
• Reduced variation in motor
behavior
• Twisting arm or neck
postures on voluntary
movement (may be
painful)
• Finds midline play
difficult, prefers toys
positioned at shoulder
width
• Switches hands during
reaching task
• Requires a lot of extra
time to initiate movement
• Voluntary movement
and emotion worsens
postures
• Reduced variation in
motor behavior
• Nonspecific
Abbreviations: CP, cerebral palsy; GMFCS, Gross Motor Function Classification
System; GMs, Prechtl Qualitative Assessment of General Movements; HINE,
Hammersmith Infant Neurological Examination; MRI, magnetic resonance
imaging; PLIC, posterior limb internal capsule; PVE, periventricular
echogenicity; PVL, periventricular leukomalacia.
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Therefore, the clinical diagnosis of cerebral palsy or high risk of
cerebralpalsyshouldalwaysbe followedbyareferral for the infant to
receivecerebralpalsy–specific interventionandfortheparentsorcare-
givers to receiveemotional support. Family concern is avalid reason
to trigger formaldiagnostic investigationsand intervention referrals.
Cerebral palsy–specific early intervention maximizes neuro-
plasticity42,43andminimizesdeleteriousmodifications tomuscleand
bone growth and development.44 Before commencing interven-
tion, unilateral vs bilateral cerebral palsy should be identified be-
causetreatmentsandlong-termmusculoskeletaloutcomesdiffer.46-48
Randomized clinical trial data are beginning to indicate the follow-
ing: (1) that infants with hemiplegic cerebral palsy who receive early
constraint-inducedmovementtherapy(CIMT)havebetterhandfunc-
tion than controls in the short term and probably substantially bet-
terhand function in the long term45; (2) that infantswithbilateral ce-
rebral palsy who receive regular surveillance and intervention have
lowerratesofhipdisplacement,contracture,andscoliosis46-48(based
on population register data); (3) that infants with any type and to-
pographyofcerebralpalsywhoreceiveGoals–Activity–MotorEnrich-
ment (GAME), which is an early, intense, enriched, task-specific,
training-based interventionathome,havebettermotorandcognitive
skills at 1 year than those who receive usual care49; and (4) that im-
provements are even betterwhen intervention occurs at home50,51
becausechildren learnbest insupportednatural settingswheretrain-
ing ispersonalized to their enjoyment.Task-specific,motor training–
basedearly intervention(eg,GAME49andCIMT45)arerecommended
as the new paradigm of care for cerebral palsy because they induce
neuroplasticityandproducefunctionalgains.52Largerreplicationran-
domizedclinical trials areunderway, including the following: (1)Ran-
domised Trial of Rehabilitation Very Early in Congenital Hemiplegia
(REACH)(ACTRN12615000180516)(n = 150)CIMTvsbimanual53and
(2) GAME (ACTRN12617000006347) (n = 300) GAME vs usual
care.54 In addition, regenerative agents to induce brain repair are
beingstudied, including(1)PreventingAdverseOutcomesofNeonatal
Hypoxic Ischaemic Encephalopathy With Erythropoietin: A
Randomised Controlled Multicentre Australian Trial (PAEAN)
(ACTRN12614000669695) (n = 300) erythropoietin plus
hypothermiavshypothermiaalone55and(2)NCT02612155(n = 160)
umbilical cord blood plus hypothermia vs hypothermia alone.56
The aim of early intervention for children with cerebral palsy
shouldbe to (1) optimizemotor, cognition, andcommunicationout-
comesusing interventions that promote learning andneuroplastic-
ity (all havemotor impairments, 1 in2have intellectualdisability, and
1 in4arenonverbal5); (2) prevent secondary impairments andmini-
mize the influence of complications that worsen function or inter-
ferewith learning (3 in 4 have chronic pain, 1 in 3 have hip displace-
ment, 1 in 4 have epilepsy, 1 in 4 have bladder control problems, 1 in
5 have a sleepdisorder, 1 in 5 have sialorrhea, 1 in 10 are blind, 1 in 15
require tube feeding, and 1 in 25 are deaf5); and (3) promoteparent
or caregiver copingandmental health to reduce stress, anxiety, and
depression,whicharecompoundedwhenabehaviordisorder ispres-
ent (1 in 4 have behavior disorders). Recommendations from best
available evidence are listed below.
Early Interventions to OptimizeMotor, Cognition,
and Communication Skills
For motor and cognition, physical and occupational therapy inter-
ventions should use child-initiated movement, task-specific prac-
tice, and environmental adaptations that stimulate independent
task performance.52 These include Learning Games Curriculum
(diplegia),57 CIMT or bimanual (hemiplegia),45 and GAME (all
subtypes).49
For communication, speech language pathology interven-
tions should foster parent-infant transactions and provide
compensation when speech is not possible or is inadequate.
Examples include the Hanen It Takes Two to Talk and More Than
Words programs, as well as alternative and augmentative
communication.58
Interventions to Prevent Secondary Impairments
andMinimize Complications
Regarding pain, procedural pain should be avoidedwhere possible
because untreated pain elevates the risk for long-term neuro-
pathic pain.59 Recommendations include pharmacological therapy
and environmental interventions for ongoing pain and preemptive
analgesia for procedural pain.59
Orthopedics
For hips, anteroposterior pelvic radiographs every 6 to 12 months
are recommendedcommencing at age 12months. This recommen-
dation is in accord with hip surveillance guidelines.60
Neurologic
For epilepsy, standard antiepileptic pharmacological management
is recommended.5
Urinary Tract
For the bladder, medical investigations should be conducted be-
cause abnormal anatomical findings are common.5 Standard toilet
training should be provided over a longer duration because control
may take longer.5
Sleep
For sleep, specialist assessments and early treatment are recom-
mendedbeforesecondaryacademicandbehavioralproblemsemerge.
Examples include sleephygiene, parental education, spasticityman-
agement,melatonin (2.5-10mg), and gabapentin (5mg/kg).5
Oral Care
For sialorrhea, botulinum toxin A, benztropine mesylate, or glyco-
pyrrolate should be considered.61
Ophthalmologic Issues
Vision canbe assessed in the first 48hours of life using the early as-
sessment of visual function in full-term newborns by Ricci et al.62
Any infant with abnormal vision at term-equivalent age should re-
ceive vision intervention and be reassessed at 3 months.63 Vision
intervention is recommended.
Feedings
For nonoral feeding, swallowing safety should be comprehensively
assessed if concerns or clinical history of pneumonia exists be-
cause it is the leading cause of death in individuals with cerebral
palsy64 and ismitigated by tube feeding.65Weight should bemea-
sured regularly because severe physical disability elevates the risk
for malnutrition.5
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Aural
For hearing, standard early hearing accommodations are
recommended.5
Interventions to Promote Parent or Caregiver Coping
andMental Health
Parental education in behavior management is recommended. An
example is the Positive Parenting Program (Triple P).66
Parent-child attachment interventions are also helpful. Kanga-
rooMother Care67 andmusic therapy68 are examples.
Finally, parentor caregivermental health interventions69,70 are
suggested. One such intervention is Acceptance and Commitment
Therapy (ACT).66
Discussion
Clinical Bottom Line
• Infantswith cerebral palsy require anearly diagnosis becausemo-
tor and cognitive gains are greater from diagnostic-specific early
intervention.
• An interim diagnosis of high risk of cerebral palsy should be used
if a diagnosis of cerebral palsy cannot yet be used with certainty.
• Clinical signs emerge and evolve before age 2 years. Therefore, a
combination of standardized tools should be used to predict risk.
• Before 5 months’ corrected age, MRI, GMs, or the HINE are most
predictive of risk for cerebral palsy.
• After 5months’ corrected age,MRI and theHINEaremost predic-
tive of risk for cerebral palsy.
• In countries of low to middle income where MRI is not available,
the HINE is recommended.
• Topography and severity of cerebral palsy are important to estab-
lish forclinicalpurposes.Magnetic resonance imagingandtheHINE
provide guidance.
• Falsepositivesoccur lessthan5%ofthetimewithstandardizedtools.
• Falsenegatives resulting in latediagnosesand late interventionare
detrimental to parents, caregivers, and infants.
Limitations
This review article has some limitations. First, our literature search
revealed that almost all studies focus on identifying cerebral palsy
in infants with newborn discernible risks (eg, prematurity and en-
cephalopathy)because these infantsaremoreoften innewborn fol-
low-up. Little has been published about early diagnosis in the 50%
of all cerebral palsy cases that are discernible later in infancy after a
seemingly uneventful pregnancy and birth because these samples
are difficult to assemble. Advances in genetics and understanding
of congenital anomaliesmayprovidemorecluesabouthowto iden-
tify these children earlier. Second, no study to date has investi-
gated the combinedpredictivepower of 3ormoreof the individual
tools identified in this review article and represents a gap in the lit-
erature.Third,wehavenotreviewedordiscussedthe literatureabout
evidence-based testing for other childhood disabilities on the dif-
ferential diagnosis list. Fourth, we have not provided a systematic
descriptionof theearly interventionevidence.More informationon
assessment tools andearly intervention is contained ina relatedbut
separate clinical guideline that is being developed from systematic
review data.
Conclusions
Cerebral palsy or high risk of cerebral palsy can be diagnosed
accurately and early using clinical reasoning and a combination of
standardized tools. High-quality evidence indicates that, for
infants with newborn-detectable risks before 5months’ corrected
age, the GMs assessment plus neonatal MRI is more than 95%
accurate and is thus recommended. For infants with infant
detectable risks after 5 months’ corrected age, the HINE plus neo-
natal MRI is more than 90% accurate and is therefore recom-
mended. The accuracy of these diagnostic methods in infants
with later infancy discernible risks for cerebral palsy is not yet
known, but they are conditionally recommended. Accurate early
diagnosis is possible even when assessments of GMs are not avail-
able or MRI is not safe or affordable (eg, in countries of low to
middle income) by using the HINE, which detects cerebral palsy
with more than 90% accuracy and provides objective informa-
tion about severity. Early detection of high risk of cerebral palsy,
followed by cerebral palsy–specific early intervention, is recom-
mended and should be the standard of care to optimize infant
neuroplasticity, prevent complications, and enhance parent and
caregiver well-being.
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